Belgian pharma company UCB will receive the ‘at risk co-development funding’ to directly finance six drug projects, in a deal the bank says showcases the new InnovFin scheme’s aim of boosting European innovation
When entrepreneur Hermann Hauser laid the foundations for the UK’s Catapult research initiatives, he held up Germany’s Fraunhofer institutes as role models. The UK now has both models in action
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.